TW570920B - 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders - Google Patents

4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders Download PDF

Info

Publication number
TW570920B
TW570920B TW088121125A TW88121125A TW570920B TW 570920 B TW570920 B TW 570920B TW 088121125 A TW088121125 A TW 088121125A TW 88121125 A TW88121125 A TW 88121125A TW 570920 B TW570920 B TW 570920B
Authority
TW
Taiwan
Prior art keywords
formula
trans
group
melting point
hydrogen
Prior art date
Application number
TW088121125A
Other languages
English (en)
Chinese (zh)
Inventor
Jean-Paul Rene Marie A Bosmans
Ann Louise Gabrielle Meulemans
Cleyn Michel Anna Jozef De
Henricus Jacobus Maria Gijsen
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of TW570920B publication Critical patent/TW570920B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
TW088121125A 1998-12-22 1999-12-03 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders TW570920B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98204411 1998-12-22

Publications (1)

Publication Number Publication Date
TW570920B true TW570920B (en) 2004-01-11

Family

ID=8234539

Family Applications (1)

Application Number Title Priority Date Filing Date
TW088121125A TW570920B (en) 1998-12-22 1999-12-03 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders

Country Status (34)

Country Link
US (2) US6544997B1 (no)
EP (1) EP1140915B1 (no)
JP (1) JP4615725B2 (no)
KR (1) KR100633680B1 (no)
CN (1) CN1150190C (no)
AR (1) AR024240A1 (no)
AT (1) ATE297917T1 (no)
AU (1) AU770397B2 (no)
BG (1) BG64953B1 (no)
BR (1) BR9916491A (no)
CA (1) CA2355857C (no)
CZ (1) CZ300851B6 (no)
DE (1) DE69925865T2 (no)
DK (1) DK1140915T3 (no)
EA (1) EA003608B1 (no)
EE (1) EE200100335A (no)
ES (1) ES2245131T3 (no)
HK (1) HK1039114B (no)
HR (1) HRP20010445A2 (no)
HU (1) HUP0104838A3 (no)
ID (1) ID28953A (no)
IL (1) IL143858A (no)
MY (1) MY121852A (no)
NO (1) NO321324B1 (no)
NZ (1) NZ512871A (no)
PL (1) PL197409B1 (no)
PT (1) PT1140915E (no)
SI (1) SI1140915T1 (no)
SK (1) SK285829B6 (no)
TR (1) TR200101962T2 (no)
TW (1) TW570920B (no)
UA (1) UA71591C2 (no)
WO (1) WO2000037461A1 (no)
ZA (1) ZA200105135B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1547593A4 (en) * 2002-09-12 2009-12-23 Nagase Chemtex Corp MEDICINAL COMPOSITION
EA009464B1 (ru) * 2003-06-19 2007-12-28 Янссен Фармацевтика Н.В. Бензамиды 4-(аминометил)пиперидина, замещённого гидроксикарбонилфенилом, в качестве антагонистов 5нт-рецепторов
EP2305254A1 (en) 2003-06-19 2011-04-06 Janssen Pharmaceutica NV Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists for the treatment of gatrointestinal conditions
EP1638961B1 (en) * 2003-06-19 2009-11-18 Janssen Pharmaceutica N.V. Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
PT1638959E (pt) * 2003-06-19 2007-12-12 Janssen Pharmaceutica Nv 4-(aminometil)piperidinobenzamidas antagonistas de 5ht4
JO2478B1 (en) * 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
AP2184A (en) * 2003-09-03 2010-12-02 Pfizer Benzimidazolone compounds having 5-HT4 receptor agonistic activity.
US7964727B2 (en) * 2003-11-24 2011-06-21 Pfizer Inc. Quinolonecarboxylic acid compounds having 5-HT4 receptor agonistic activity
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
EP1758891A2 (en) 2004-06-15 2007-03-07 Pfizer Japan Inc. Benzimidazolone carboxylic acid derivatives
US20060035890A1 (en) * 2004-08-10 2006-02-16 Amit Banerjee Compounds and methods for the treatment of ubiquitin conjugating disorders
JP5042028B2 (ja) * 2004-11-05 2012-10-03 セラヴァンス， インコーポレーテッド キノリノン−カルボキサミド化合物
JP5086091B2 (ja) * 2004-11-05 2012-11-28 セラヴァンス， インコーポレーテッド ５−ｈｔ４受容体アゴニスト化合物
JP5159317B2 (ja) * 2004-12-22 2013-03-06 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物
WO2006094063A1 (en) * 2005-03-02 2006-09-08 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8377968B2 (en) 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
US10208023B2 (en) 2013-03-01 2019-02-19 Mark G. DeGiacomo Heterocyclic inhibitors of the sodium channel
US20180305334A1 (en) * 2015-10-14 2018-10-25 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
US20220241258A1 (en) 2019-07-11 2022-08-04 Praxis Precision Medicines, Inc. Formulations of t-type calcium channel modulators and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
NZ243993A (en) 1991-08-20 1994-10-26 Smithkline Beecham Plc Pharmaceutical compositions having 5-ht4 receptor antagonist activity and selected compounds having such activity
JP3294611B2 (ja) * 1991-09-12 2002-06-24 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ４レセプター・アンタゴニスト
CA2105072C (en) * 1992-01-23 1998-07-28 Hiroshi Nagase Morphinan derivative and its pharmaceutical applications
AU667874B2 (en) * 1992-02-06 1996-04-18 Smithkline Beecham Plc Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
GB9219163D0 (en) 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AU5150393A (en) 1992-10-13 1994-05-09 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
NZ257545A (en) 1992-11-05 1997-01-29 Smithkline Beecham Plc Heterocyclic (especially piperidine) derivatives and pharmaceutical compositions
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9507882D0 (en) 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
ATE250931T1 (de) * 1996-02-15 2003-10-15 Janssen Pharmaceutica Nv Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
TW445263B (en) * 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
TW402591B (en) * 1997-07-11 2000-08-21 Janssen Pharmaceutica Nv Monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
DE69935600T2 (de) * 1998-09-10 2007-12-06 F. Hoffmann-La Roche Ag Dihydrobenzodioxincarbonsäureamid- und ketonderivate als 5-ht4-rezeptorantagonisten
DE10217868A1 (de) * 2002-04-22 2003-10-30 Jomed N V Ballon-Katheter

Also Published As

Publication number Publication date
NO20012858D0 (no) 2001-06-08
SK8592001A3 (en) 2002-02-05
WO2000037461A1 (en) 2000-06-29
NO321324B1 (no) 2006-04-24
US6544997B1 (en) 2003-04-08
PL197409B1 (pl) 2008-03-31
CA2355857A1 (en) 2000-06-29
EE200100335A (et) 2002-08-15
NO20012858L (no) 2001-06-08
NZ512871A (en) 2002-11-26
CZ300851B6 (cs) 2009-08-26
EA200100710A1 (ru) 2001-12-24
JP2002533337A (ja) 2002-10-08
HK1039114B (zh) 2005-08-19
MY121852A (en) 2006-02-28
SI1140915T1 (sl) 2005-12-31
AR024240A1 (es) 2002-09-25
SK285829B6 (sk) 2007-09-06
AU2432800A (en) 2000-07-12
IL143858A0 (en) 2002-04-21
BR9916491A (pt) 2001-09-04
IL143858A (en) 2005-03-20
EP1140915B1 (en) 2005-06-15
ES2245131T3 (es) 2005-12-16
PL348417A1 (en) 2002-05-20
HUP0104838A2 (hu) 2002-07-29
PT1140915E (pt) 2005-11-30
DE69925865D1 (de) 2005-07-21
ID28953A (id) 2001-07-19
CN1331690A (zh) 2002-01-16
ZA200105135B (en) 2002-06-21
EA003608B1 (ru) 2003-06-26
CN1150190C (zh) 2004-05-19
HRP20010445A2 (en) 2002-06-30
CA2355857C (en) 2008-10-28
US7205410B2 (en) 2007-04-17
KR20010080293A (ko) 2001-08-22
CZ20012117A3 (cs) 2001-10-17
BG105571A (en) 2002-01-31
US20030181456A1 (en) 2003-09-25
EP1140915A1 (en) 2001-10-10
BG64953B1 (bg) 2006-10-31
KR100633680B1 (ko) 2006-10-11
HUP0104838A3 (en) 2003-05-28
DE69925865T2 (de) 2006-05-11
AU770397B2 (en) 2004-02-19
DK1140915T3 (da) 2005-10-10
ATE297917T1 (de) 2005-07-15
TR200101962T2 (tr) 2002-04-22
JP4615725B2 (ja) 2011-01-19
UA71591C2 (en) 2004-12-15
HK1039114A1 (en) 2002-04-12

Similar Documents

Publication Publication Date Title
TW570920B (en) 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders
TW577886B (en) (Benzofuran or benzopyran) derivatives having fundic relaxation properties
TW548103B (en) Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
EP0720609B1 (en) 3-(5-tetrazolyl-benzyl)amino-piperidine derivatives and antagonists of tachykinins
TW504510B (en) 2,4-diaminopyrimidine derivatives
CN107286077A (zh) 一种选择性的c-kit激酶抑制剂
TW577887B (en) Polymorphic form I of a tachykinin receptor antagonist
HU228128B1 (hu) Tachikinin-receptor antagonista hatású 1-(1,2-diszubsztituált piperidinil)-4-szubsztituált piperidinszármazékok
CN103080087A (zh) 哌啶衍生物及其用于治疗代谢紊乱的用途
CN112341439A (zh) 一种免疫调节剂
CN101213187A (zh) 作为rho-激酶抑制剂的异喹啉衍生物
WO2013123824A1 (zh) 聚乙二醇与纳洛酮的结合物及其药物组合物和应用
CN112824398A (zh) 一种免疫调节剂
HU229766B1 (hu) 1-(1,2-diszubsztituált piperidinil)-4-(kondenzált imidazolil)-piperidin-származékok
CN100537565C (zh) 作为5ht4-拮抗剂的4-(氨甲基)-哌啶苯甲酰胺
CN108884093A (zh) 6,7,8,9-四氢-5H-吡啶并[2,3-d]氮杂*多巴胺D3配体
EP1238970B1 (en) Cycloamine ccr5 receptor antagonists
CN114728967A (zh) 作为jak抑制剂的三并杂环类化合物及其应用
WO2023205786A1 (en) Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditions
CN100516066C (zh) 供治疗胃底松弛作用损伤的化合物
TW200904449A (en) Dibenzo[b,f][1,4]oxazapine compounds
HUT72740A (en) Dimethylbenzofurans and dimethylbenzopyrans and they use for preparing pharmaceutical compositions having 5-ht3 antagonistic activity
JPH06507162A (ja) 抗セロトニン類、それらの製造およびそれらを含有する薬物
WO2021159372A1 (zh) Jak抑制剂在制备治疗jak激酶相关疾病药物中的应用
TWI289559B (en) Aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives

Legal Events

Date Code Title Description
GD4A Issue of patent certificate for granted invention patent
MM4A Annulment or lapse of patent due to non-payment of fees